Jan 28, 2015 7:00am EST Immunovaccine Study Demonstrates Early Protection Against Anthrax with Single Dose Experimental Vaccines
Jan 20, 2015 7:00am EST Health Canada Clears Immunovaccine to Conduct Phase I Clinical Trial of Respiratory Syncytial Virus (RSV) Vaccine
Dec 10, 2014 7:00am EST Immunovaccine Receives FDA Fast Track Designation for DPX-Survivac for Treatment of Ovarian Cancer
Nov 19, 2014 8:05am EST Health Canada Clears Immunovaccine to Conduct Phase II Clinical Trial of DPX-Survivac in Recurrent Lymphoma
Nov 14, 2014 4:39pm EST Immunovaccine Announces Financial Results for Quarter Ended September 30, 2014
Nov 12, 2014 8:05am EST Immunovaccine Receives Conditional Approval to Graduate to Toronto Stock Exchange (TSX)
